You are here: Home > Therapeutics (former) > Analgesic and Reinforcing Properties of 9-THC-Hemisuccinate in Adjuvant-Arthritic Rats

J Cannabis Ther 2001(3/4):133-152

Arthritis

Analgesic and Reinforcing Properties of 9-THC-Hemisuccinate in Adjuvant-Arthritic Rats

Author
S.L. Broom, K.J. Sufka, M.A. ElSohly, S.A. Ross

Abstract
The use of delta-9-THC hemisuccinate (HS) in a suppository formulation is an attempt to develop a cannabinoid possessing possible therapeutic effects with a minimal side effect profile. The purpose of this study was to investigate the antinociceptive and reinforcing effects of rectally administered delta-9-THC-HS in rats. Tests were conducted in two groups of animals: Complete Freund's adjuvant-inflamed animals (CFA) and non-inflamed controls. A hotplate test was administered to index hyperalgesia and possible analgesic effects of delta-9-THC-HS on thermal nociception. CFA animals demonstrated shorter latencies than non-inflamed animals. The highest dose of delta-9-THC-HS produced longer hotplate latencies. Additionally, the reinforcing properties of 9-THC-HS were evaluated using the Conditioned Place Preference (CPP) paradigm. Delta-9-THC-HS produced an increase in preference scores in non-inflamed animals (positive reinforcement), but did not affect preference scores in CFA animals. These data suggest that delta-9-THC-HS has therapeutic potential and is unlikely to possess an abuse liability when used in the context of chronic pain.


Keywords
delta-9-THC, adjuvant-inflamed, rat, hotplate, conditioned place preference

PDF of the full text ]

Free Online Events 2020

You can find all information here.

The IACM is holding a free webinar series and a free anniversary online meeting from October to November 2020

All webinars will be held in English with subtitles in German, French, Spanish, and Portuguese. All webinars will be available online until March 2021

The anniversary online meeting to celebrate the IACM's 20th anniversary and to honour the 90th birthday of Raphael Mechoulam will be a live session only on the 5th November 2020.

The speakers in the webinar series are Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli, and Ethan Russo.

You can find all information here.
 

IACM Conference 2021

The 12th IACM Conference on Cannabinoids in Medicine will be held in Basel, Switzerland, from 14 to 16 October 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.